Well, a couple of things ... One, I was surprised that the FDA stuck to their deadline of March 15 for issuing a ruling on the NDA for cross-linking. When has the government ever been good about sticking to a deadline, especially lately?Two, I knew it was too good to be true to hope that they'd rule in favor of approving the procedure. Mind you, I don't think that I read anywhere that this response would include approval, especially since our study is still on-going, but I did have high hopes! Check out the original press release from Avedro here. - jw |